Zogenix Provides Update on Zohydro(TM) ER Regulatory Review

[at noodls] – SAN DIEGO, Feb. 26, 2013 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, … more

View todays social media effects on ZGNX

View the latest stocks trending across Twitter. Click to view dashboard

See who Zogenix is hiring next, click here to view